Editöre Mektup
Yıl 2020,
Cilt: 45 Sayı: 2, 756 - 757, 30.06.2020
Anahtar Kelimeler
Destekleyen Kurum
Yok
Proje Numarası
Yok
Kaynakça
- 1. Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Review. PubMed PMID: 26760521; PubMed Central PMCID: PMC4871266.
- 2. Kyriakides T, Angelini C, Schaefer J, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010; 17:767–773. [PubMed: 20402744]
- 3. Lilleng H, Abeler K, Johnsen SH, et al. Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study. Neuromuscul Disord. 2011; 21:494–500. [PubMed: 21592795]
Yıl 2020,
Cilt: 45 Sayı: 2, 756 - 757, 30.06.2020
Anahtar Kelimeler
Proje Numarası
Yok
Kaynakça
- 1. Moghadam-Kia S, Oddis CV, Aggarwal R. Approach to asymptomatic creatine kinase elevation. Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120. Review. PubMed PMID: 26760521; PubMed Central PMCID: PMC4871266.
- 2. Kyriakides T, Angelini C, Schaefer J, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol. 2010; 17:767–773. [PubMed: 20402744]
- 3. Lilleng H, Abeler K, Johnsen SH, et al. Variation of serum creatine kinase (CK) levels and prevalence of persistent hyperCKemia in a Norwegian normal population. The Tromsø Study. Neuromuscul Disord. 2011; 21:494–500. [PubMed: 21592795]
Toplam 3 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | Türkçe |
|---|---|
| Konular | İç Hastalıkları |
| Bölüm | Editöre Mektup |
| Yazarlar | |
| Proje Numarası | Yok |
| Yayımlanma Tarihi | 30 Haziran 2020 |
| Kabul Tarihi | 22 Mart 2020 |
| Yayımlandığı Sayı | Yıl 2020 Cilt: 45 Sayı: 2 |
